Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ahmedabad
Clinical trial register · India

Clinical Trials in Ahmedabad, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca25 Eli Lilly and Company16 Bristol-Myers Squibb12 Novartis Pharmaceuticals11 Hoffmann-La Roche7
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Ahmedabad

159 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Eli Lilly and Company
Phase 3
2,115
Ahmedabad, Baroda, Belagavi, Chennai, Guntur, Hubli, Kanpur, Noida
2026-12
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Guntur, Vijayawada, Raipur, Ahmedabad, Surat, Vadodara, Faridabad, Gurugram
2026-10-26
Not yet open
Eli Lilly and Company
Phase 4
30
Ahmedabad, Bengaluru, Bhubaneswar, Hisar, Kolkata, Kozhikode, Mumbai (E), New Delhi
2026-10
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Ahmedabad, Bangalore, Gūrgaon, Kottayam, Madurai, Nashik, New Delhi, Vadodara
2026-09-24
Recruiting
Anxo Pharmaceutical Co., Ltd.
Phase 1
48
Ahmedabad, Gandhinagar, Nagar
2026-09-14
Recruiting
Boehringer Ingelheim
Phase 3
600
Ahmedabad, Bhubaneswar, Cuttack, Hyderabad, Afzalgunj, Kolhāpur, Lucknow, Nagpur, Nashik
2026-08-24
Recruiting
Corium Innovations, Inc.
Phase 1
250
Ahmedabad
2026-08-10
Recruiting
Eli Lilly and Company
Phase 2
606
Ahmedabad, Allahabād, Bangalore, Bhopal, Chhatrapati Sambhajinagar, Lucknow, Nagpur, New Delhi
2026-08-07
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
230
Ahmedabad, Ajmer
2026-07-24
Recruiting
Eli Lilly and Company
Phase 3
170
Ahmedabad, Aligarh, Bhubaneswar, Guntur, Mumbai, Nashik, New Delhi
2026-07-08
Recruiting
YS Life Science Co., Ltd.
Phase 3
600
Ahmedabad, Nagpur, Nerul, Bhubaneswar, Kolkata
2026-06-02
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Guntur, Ahmedabad, Vadodara, Belagavi, Mangalore, Manipal, Kochi, Nagpur
2026-05-11
Recruiting
Biogen
Phase 3
30
Ahmedabad
2026-04-28
Not yet open
Venus Remedies Limited
Phase 1
48
Ahmedabad
2026-04
Recruiting
Laboratoires Thea
Phase 2
120
Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat
2026-03-24
Recruiting
Boehringer Ingelheim
Phase 2
132
Ahmedabad, Bhubaneswar, Hyderabad, Kozhikode, Lucknow, Pune, Varanasi
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Ahmedabad, Trivandrum, Mumbai, Pune
2026-03-16
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Patna, Ahmedabad, Bangalore, Belagavi, Mysore, Nashik
2026-03-09
Recruiting
Bristol-Myers Squibb
Phase 1
46
Hyderabad, Ahmedabad, Bangalore, Mysuru, Nagpur, Pune, Bhubaneswar, Secunderabad
2026-02-27
Active, closed
Eli Lilly and Company
Phase 4
344
Ahmedabad, Ajmer, Allahabād, Bengaluru, Bhubaneswar, Chennai, Coimbatore, Guwahati
2026-02-27
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Bikaner, Calicut, Chandigarh, Coimbatore
2026-02-17
Recruiting
Boehringer Ingelheim
Phase 3
286
Ahmedabad, Bhubaneswar, Bikaner, Chennai, Dehradun, Delhi, Hyderabad, Kozhikode
2026-02-16
Recruiting
AstraZeneca
Phase 3
2,130
Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mohali, Mumbai, New Delhi, Varanasi
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 3
650
Ahmedabad, Hyderabad, Varanasi, Kolkata, Delhi, New Delhi
2025-12-02
Recruiting
Eli Lilly and Company
Phase 3
7,140
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Guntur, Hubli, Hyderabad, Kanpur
2025-12-01
Active, closed
Bayer
Phase 2
60
Ahmedabad, New Delhi, Coimbatore, Kolkata
2025-11-19
Recruiting
iIDEAS Group Holdings Limited
Not applicable
5
Ahmedabad
2025-11-11
Recruiting
Eli Lilly and Company
Phase 2
252
Ahmedabad, Chennai, Coimbatore, Hubli, Hyderabad, New Delhi, Pune, Rajkot
2025-11-10
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ahmedabad, Gurugram, Bengaluru, Mumbai, Nagpur, New Delhi, Howrah
2025-11-05
Recruiting
Eli Lilly and Company
Phase 3
4,500
Ahmedabad, Bhubaneswar, Chandigarh, Ernākulam, Guntur, Hyderabad, Jaipur, Kochi
2025-10-15
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Ahmedabad, Belagavi, Bhāratnagar, Chhatrapati Sambhajinagar, Coimbatore, Dehradun, Guntur, Gurugram
2025-09-06
Active, closed
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
NCT07004972Symptomatic Obstructive Hypertrophic Cardiomyopathy
DrugMavacamten
Bristol-Myers Squibb
Phase 4
50
Hyderabad, Ahmedabad, Surat, Gurgaon, Belagavi, Mangalore, Ernākulam, Kottayam
2025-09-04
Recruiting
Johnson & Johnson Private Limited
Phase 4
100
Ahmedabad, Chandigarh, Chennai, Gorakhpur, Hyderabad, Mumbai, New Delhi, Patna
2025-08-12
Recruiting
Mapi Pharma Ltd.
Phase 1/2
24
Ahmedabad
2025-08-01
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ahmedabad, Bengaluru, Bikaner, Kanpur, Kolkata, Maharashtra, Nagpur, Nashik
2025-07-22
Recruiting
Bristol-Myers Squibb
Phase 3
426
Ahmedabad, Hyderabad, Varanasi, Kolkata, Delhi, New Delhi
2025-07-10
Recruiting
AstraZeneca
Phase 3
15,100
Ahmedabad, Bangalore, Belagavi, Bikaner, Calicut, Chennai, Chhatrapati Sambhajinagar, Coimbatore
2025-06-04
Not yet open
SAVA Healthcare Limited
Not applicable
32
Ahmedabad
2025-05-15
Recruiting
Biogen
Phase 3
454
Hyderabad, Raipur, Ahmedabad, Nadiād, Bangalore, Kozhikode, Trivandrum, Mumbai
2025-05-08
Recruiting
AstraZeneca
Phase 3
1,220
Ahmedabad, Bangalore, Binnāguri, Dehradun, Delhi, Hyderabad, Mumbai, Nashik
2025-05-06
Recruiting
Takeda
Phase 3
225
Ahmedabad, Ernākulam, Mumbai, New Delhi, Ludhiana, Vellore, Ghaziabad, Kolkata
2025-05-06
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Visakhapatnam, Ahmedabad, Thiruvananthapuram, Mumbai, New Delhi, Bhubaneswar, Madurai, Hyderabad
2025-04-24
Recruiting
iIDEAS Group Holdings Limited
Not applicable
5
Ahmedabad
2025-04-22
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT06512883Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
14
Ahmedabad
2025-04-17
Recruiting
Epygenix
Phase 3
260
Hyderabad, Ahmedabad, Surat, Calicut
2025-04-09
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Ahmedabad, Dehli, Kochi, Kolkata
2025-03-31
Recruiting
Eli Lilly and Company
Phase 3
700
Ahmedabad, Chennai, Chhatrapati Sambhajinagar, Mumbai, Namakkal, Patna, Pune, Thalassery
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Ahmedabad, Delhi, Kolkata, Mumbai, Nagpur, Nashik, Pune, Vadodara
2025-03-19
Recruiting
AstraZeneca
Phase 3
990
Ahmedabad, Aligarh, Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Faridabad
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Ahmedabad, Ajmer, Bangalore, Belagavi, Dehradun, Delhi, Gūrgaon, Hyderabad
2025-03-14
Recruiting
Pfizer
Phase 3
723
Guntur, Ahmedabad, Mangaluru, Mumbai, Nagpur, Nashik, Ajmer, Lucknow
2025-03-11
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi, Noida
2025-02-21
Not yet open
Vedic Lifesciences Pvt. Ltd.
Not applicable
150
Ahmedabad, Pune, Jaipur, Varanasi, Delhi
2025-02-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Ahmedabad, Bhubaneswar, Hubballi, Kolkata, Mysuru, New Delhi, Noida, Surat
2025-01-09
Recruiting
GlaxoSmithKline
Phase 3
520
Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research
2024-12-16
Active, closed
Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, India
NCT07251218Eco-anxiety, PTSD - Post Traumatic Stress Disorder, Resilience, Anxiety
Aditi Bunker
Not applicable
800
Ahmedabad
2024-12-01
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
400
Ahmedabad, Kolkata, Miraj, Mumbai, Varanasi
2024-11-27
Recruiting
GlaxoSmithKline
Phase 3
324
Ahmedabad, Bikaner, Kolkata, Mumbai, Surat
2024-11-13
Active, closed
Regeneron Pharmaceuticals
Phase 2
19
Ahmedabad, Surat, Kochi, Mumbai, New Delhi, Jaipur
2024-09-30
Recruiting
Assessing the Effects of Cool Roofs on Indoor Environments and Health
NCT06579950Resting Heart Rate, Blood Glucose Control, Depression, Heat-related Symptoms
Aditi Bunker
Not applicable
3,200
Ahmedabad
2024-09-04
Active, closed
Assessing the Effect of Cool Roofs on Health Using Smartwatches
NCT06579963Heart Rate, All-day Steps, Distance Walked, Active Minutes
Aditi Bunker
Not applicable
800
Ahmedabad
2024-09-04
Recruiting
The George Institute
Phase 3
2,000
Visakhapatnam, Patna, Raipur, Dehradun, Ahmedabad, Vadodara, Mangaluru, Meppādi
2024-09-04
Active, closed
Celldex Therapeutics
Phase 3
976
Surat, Vadodara, Nagpur, Nashik, Pune, Jaipur, Kanpur, Ahmedabad
2024-07-19
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi, Pune
2024-07-18
Recruiting
Colorado Prevention Center
Phase 3
1,500
Ahmedabad, Bangalore, Nagpur, New Delhi
2024-07-09
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Guntur, Visakhapatnam, Raipur, Ahmedabad, Surat, Vadodara, Bengaluru, Mangaluru
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Ahmedabad, Bangalore, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow
2024-06-20
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi
2024-05-21
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
384
Ahmedabad, Chhatrapati Sambhajinagar, Nashik, Varanasi
2024-05-14
Active, closed
Sanofi
Phase 3
1,541
Ahmedabad, Belagavi, Chandigarh, Faridabad, Kolkata, Nagpur, Pune
2024-05-08
Recruiting
Institute of Liver and Biliary Sciences, India
Observational
250
Guindy, Ahmedabad, Surat, Srinagar, Bengaluru, Mangalore, Kochi, Thiruvananthapuram
2024-05-02
Recruiting
AstraZeneca
Phase 3
3,850
Ahmedabad, Ajmer, Amritsar, Bangalore, Belagavi, Coimbatore, Dehradun, Delhi
2024-04-12
Active, closed
AstraZeneca
Phase 3
594
Ahmedabad, Hyderabad, Mumbai, New Delhi
2024-03-04
Recruiting
AstraZeneca
Phase 3
5,250
Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwārka
2024-02-21
Recruiting
Colorado Prevention Center
Phase 3
5,200
Guntur, Vijayawada, Patna, Ahmedabad, Kochi, Nagpur, Nashik, New Delhi
2024-01-17
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur
2024-01-10
Active, closed
Bristol-Myers Squibb
Phase 3
190
Ahmedabad, Gurugram, Bengaluru, Pune, New Delhi
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
1,264
Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhāpur
2023-12-21
Active, closed
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc.
Phase 2
37
Ahmedabad, Kannur, Visakhapatnam, Kolhāpur, Dehradun, Madurai, Hyderabad, Kolkata
2023-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Ahmedabad, Bangalore, Belagavi, Mysore, Nagpur, Nashik, New Delhi, Bikaner
2023-11-15
Active, closed
AstraZeneca
Phase 3
314
Ahmedabad, Delhi, Gurugram, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi
2023-11-08
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Ahmedabad, New Delhi
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Ahmedabad, Bengaluru, New Delhi, Bhubaneswar
2023-10-24
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
40
Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Srinagar, Belagavi, Kochi
2023-10-19
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-09-14
Recruiting
Hoffmann-La Roche
Phase 3
230
Ahmedabad, Surat, Gurugram, Mumbai, Nagpur, NEW Delhi Delhi, Kolkata
2023-09-08
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur
2023-06-28
Active, closed
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryāna, Jaipur, Lucknow
2023-06-26
Active, closed
Viatris Innovation GmbH
Phase 3
451
Ahmedabad, Chennai, Hyderabad, Kolkata, Nagpur, Nashik, New Delhi, Pune
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 4
85
Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad
2023-06-05
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
470
Ahmedabad, Ajmer, Bārāmati, Bikaner, Chandigarh, Guwahati, Kolhāpur, Nagpur
2023-05-02
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi, Dehradun
2023-04-21
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Guntur, Ahmedabad, Bangalore, Belagavi, Mangalore, Manipal, Mysore, Kochi
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Guntur, Hyderabad, Vijayawada, Guwahati, Raipur, Ahmedabad, Surat, Vadodara
2023-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Ahmedabad, Ajmer, Anand, Bangalore, Belagavi, Bhubaneswar, Bikaner, Chennai
2023-02-15
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Ahmedabad, Rishikesh
2023-02-03
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Hyderabad, Secunderabad, Ahmedabad, Rajkot, Surat, Vadodara, Gurgaon, Bangalore
2023-01-16
Active, closed
Bristol-Myers Squibb
Phase 3
516
Vizianagaram, Ahmedabad, Surat, Gurugram, Bengaluru, Hyderabad
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
513
Ahmedabad, Hubli, Mysore, Nagpur, Vellore, Hyderabad, Secundarabad
2023-01-12
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Hyderabad, Kochi, Rudrapur, Ahmedabad, Ajmer, Bangalore, Bhubaneswar, Chandigarh
2022-12-27
Active, closed
Viatris Innovation GmbH
Phase 3
470
Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune
2022-12-13
Recruiting
AstraZeneca
Phase 3
3,527
Ahmedabad, Belagavi, Chennai, Dehradun, Gurugram, Gūrgaon, Hyderabad, Kanpur
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Ahmedabad, New Delhi, Chennai, Varanasi, Rishikesh
2022-11-21
Recruiting
Bayer
Phase 3
100
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-11-08
Active, closed
Eli Lilly and Company
Phase 3
15,374
Ahmedabad, Bikaner, Hyderabad, Lucknow, Ludhiana, Mumbai, Nagpur, New Delhi
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Kanpur
2022-10-04
Recruiting
Celgene
Phase 3
810
Ahmedabad, Gurugram, Belagavi, Mumbai, Madurai, Varanasi, Ludhiana, Puducherry
2022-09-20
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Ahmedabad, New Delhi, Hyderabad
2022-08-23
Active, closed
Sanofi
Phase 2/3
1,856
Ahmedabad, Belagavi, Chandigarh, Kolkata, Nagpur, Pune
2022-08-22
Recruiting
Intech Biopharm Ltd.
Not applicable
148
Ahmedabad, Belagāve, Kolkata, New Delhi, Pune, Ulhasnagar
2022-08-15
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ahmedabad, Bangalore, Pune, New Delhi
2022-08-04
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Ahmedabad, Bengaluru, Bhubaneswar, Chennai, Gūrgaon, Hyderabad, Mumbai, New Delhi
2022-07-22
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Chandigarh, Ahmedabad, Bangalore, Bhubaneswar, Bikaner, Noida
2022-06-30
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Hyderabad, Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Pune
2022-04-05
Active, closed
Bayer
Phase 3
219
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-03-28
Active, closed
AstraZeneca
Phase 3
760
Ahmedabad, Bangalore, Delhi, Hyderabad, Jaipur, Kolkata, Mumbai, New Delhi
2022-03-28
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Ahmedabad, Bangalore, Chandigarh
2022-03-16
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Chhatrapati Sambhajinagar, Pune
2022-03-15
Active, closed
Genentech, Inc.
Phase 4
218
Hubli, Pune, Ahmedabad, Chennai, Madurai, Kolkata, Chandigarh
2022-02-28
Active, closed
AstraZeneca
Phase 3
791
Ahmedabad, Bangalore, Delhi, Howrah, Hyderabad, Jaipur, Kolkata, Marg Jaipur
2022-02-18
Active, closed
AstraZeneca
Phase 3
363
Ahmedabad, Dehradun, Delhi, Hyderabad, Kolkata, Nadiād, Pune, Secunderabad
2022-02-15
Active, closed
Sanofi
Phase 4
1,339
Ahmedabad, Chandigarh, Coimbatore, Jaipur, Jodhpur, Kozhikode, Lucknow, Mangaluru
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Guntur, Hyderabad, Ahmedabad, Vadodara, Belagavi, Manipal, Mysore, Kochi
2021-11-23
Active, closed
Hoffmann-La Roche
Phase 3
41
Ahmedabad, Gurgaon, New Delhi
2021-11-17
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Ahmedabad
2021-11-01
Active, closed
Beeline Medicines Corporation
Phase 2
248
Ahmedabad, Gurugram, Bengaluru, New Delhi, Secunderabad
2021-10-11
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Vijayawada, Patna, Ahmedabad, Surat, Vadodara, Belagavi, Amravati, Kolhāpur
2021-08-27
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Ahmedabad, Aligarh, Bangalore, Bathinda, Belagavi, Bhubaneswar, Bikaner, Chennai
2021-08-14
Active, closed
Tolmar Inc.
Phase 3
250
Vijayawada, Visakhapatnam, Ahmedabad, Surat, Bengaluru, Mysore, Nagpur, Nashik
2021-07-01
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Ahmedabad, Bangalore, Mumbai, Nashik, Pune, New Delhi, North WEST Delhi, Ratnagiri Kilminnal
2021-05-04
Recruiting
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
NCT04861558Colorectal Cancer, Peritoneal Metastases
Drugs5Fluorouracil·Irinotecan·Oxaliplatin
Uppsala University
Phase 3
213
Ahmedabad
2021-05-01
Active, closed
AstraZeneca
Phase 3
1,157
Ahmedabad, Bangalore, Bengaluru, Calicut, Gūrgaon, Mysuru, Nashik, New Delhi
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 3
751
Ahmedabad, Mumbai, Pune, New Delhi, Ludhiana, Vadapalani, Chandigarh
2021-03-24
Active, closed
AstraZeneca
Phase 3
1,371
Ahmedabad, Calicut, Delhi, Faridabad, Gūrgaon, Karamsad, Kolkata, Madurai
2021-01-28
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ahemdabad, Ahmedabad, Bangalore, Belagavi, Chhatrapati Sambhajinagar, Howrah, Hyderabad, Jaipur
2020-12-02
Active, closed
Eli Lilly and Company
Phase 3
312
Ahmedabad, Gurugram, Kanpur, Mangalore, Nagpur, New Delhi, Pune
2020-11-25
Active, closed
AstraZeneca
Phase 3
134
Ahmedabad, Ajmer, Delhi
2020-07-20
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Active, closed
AstraZeneca
Phase 3
1,012
Ahmedabad, Bangalore, Delhi, Faridabad, Kanpur, Kolkata, Madurai, Manipal
2020-07-13
Active, closed
Actelion
Phase 3
935
Ahmedabad, Bangalore, Chengalpetu, Coimbatore, Durgapur, Hyderabad, Hyderbad, Kolkata
2020-06-30
Active, closed
Sun Pharmaceutical Industries Limited
Phase 2/3
135
Ahmedabad, Lucknow, Surat
2020-01-15
Active, closed
NeoTX Therapeutics Ltd.
Phase 1
120
Ahmedabad, Jhajjar, New Delhi, Udaipur, Hyderabad
2019-10-10
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Hyderabad, Ahmedabad, Bangalore, Gūrgaon, New Delhi
2019-10-03
Recruiting
Population Health Research Institute
Phase 4
2,270
North Guwāhāti, Ahmedabad, Bangalore, Alappuzha, Thrissur, Puducherry, Pune, Thiruvananthapuram
2019-06-14
Active, closed
AstraZeneca
Phase 2
401
Ahmedabad, Jamnagar, Kochi, Mysuru, Nashik, Pune, Thiruvananthapuram
2018-12-21
Active, closed
AstraZeneca
Phase 3
825
Ahmedabad, Gūrgaon, Kolkata, Manipal, Mumbai, Mysuru, Namakkal, Nashik
2018-12-06
Active, closed
Safety and Efficacy of the ANTHEM™ CR Total Knee System
NCT03885622Non-inflammatory Degenerative Joint Disease
Smith & Nephew Pte Ltd
Observational
153
Ahmedabad, Hisar, Mohali
2018-11-23
Active, closed
Eli Lilly and Company
Phase 3
1,058
Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune
2018-07-18
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
NCT03549754Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
AstraZeneca
Observational
35,000
Ahmedabad, Kolkata, Mumbai
2018-02-17
Active, closed
Eli Lilly and Company
Phase 3
5,637
Hyderabad, Ahmedabad, Vadodara, Gurgaon, Bangalore, Trivandrum, Mumbai, Nashik
2017-07-12
Active, closed
Eli Lilly and Company
Phase 3
463
Ahmedabad, Bangalore, Mumbai, Pune, New Delhi, Ranipet, Kolkata
2016-12-05
Active, closed
AstraZeneca
Phase 3
953
Ahmedabad, Bangalore, Chennai, Gūrgaon, Karamsad, New Delhi
2015-11-03
Active, closed
ImmunityBio, Inc.
Phase 1/2
369
Visakhapatnam, Adyār, Ahmedabad, Chhatrapati Sambhajinagar, Nagpur, Pune, Mumbai, New Delhi
2014-07-21
Active, closed
Tata Memorial Hospital
Phase 3
1,600
Guwahati, Ahmedabad, Kannur, Kolhāpur, Mumbai, Pune, Sangli, Shillong
2011-12-12
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2004-09-15
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2001-07-31
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Ahmedabad, Jaipur, Kolkata, Mumbai, Secunderabad, Vellore
1991-04-01
Rows per page Showing 1–159 of 159
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-india/city/ahmedabad

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 07 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 159 of those studies with a site in Ahmedabad.

How many clinical trials are recruiting in Ahmedabad?

75 of the 159 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:16 UTC sync. A further 6 have not yet opened recruitment, 76 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ahmedabad), 159 studies
PhaseStudiesRecruitingShare
Phase 31054766%
Phase 21368.2%
Not applicable1156.9%
Observational875%
Phase 4825%
Phase 1754.4%
Phase 2/3523.1%
Phase 1/2211.3%

Most active sponsors

Lead sponsors with the most studies (Ahmedabad)
Lead sponsorStudiesRecruiting
AstraZeneca2513
Eli Lilly and Company167
Bristol-Myers Squibb124
Novartis Pharmaceuticals112
Hoffmann-La Roche72
Boehringer Ingelheim55
Janssen Research & Development, LLC40
Aditi Bunker31
Bayer31
Genzyme, a Sanofi Company33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.